Approaches sponsors, CROs, and investigators can take from the DMD experience.
Lauren P. Morgenroth, MS, CGC
Advertisement
Chief Executive Officer, TRiNDS
Articles by Lauren P. Morgenroth, MS, CGC
Advertisement
Latest Updated Articles
Rare Disease Clinical Trials: Strategies Learned from Duchenne Muscular DystrophyPublished: October 14th 2022 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
